サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1231172

バイオプリザベーションの世界市場

Biopreservation
出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 178 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
バイオプリザベーションの世界市場
出版日: 2023年03月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 178 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

バイオプリザベーションの世界市場は2030年に79億米ドルに達する

COVID-19後の変化したビジネス環境において、2022年に44億米ドルと推定されるバイオプリザベーションの世界市場は、2030年には79億米ドルに達すると予測され、2022年から2030年にかけてCAGR7.5%の成長を遂げると予測されます。バイオプリザベーションレポートで分析したセグメントの一つであるメディアは、CAGR 8.5%を記録し、分析期間終了時には51億米ドルに達すると予測されます。パンデミック後の回復を考慮し、バイオプリザベーション機器分野の成長は、今後8年間のCAGRが6％に修正されました。

米国市場は12億米ドル、中国はCAGR12.6%で成長予測

米国のバイオプリザベーション市場は、2022年には12億米ドルに達すると推定されます。世界第2位の経済大国である中国は、2022年から2030年にかけてのCAGRが12.6％となり、2030年には20億米ドルの市場規模に達すると予測されます。その他の注目すべき地域市場としては、日本とカナダがあり、2022年から2030年にかけてそれぞれ2.8％と6.4％の成長が予測されています。欧州では、ドイツがCAGR3.9%で成長すると予測されています。

調査対象企業の例

  • Atlanta Biologicals, Inc.
  • BioCision, LLC
  • BioGenix, LLC
  • BioLife Solutions, Inc.
  • Biomatrica, Inc.
  • LabVantage Solutions, Inc.
  • Panasonic Corporation
  • Qiagen, Inc.
  • Thermo Fisher Scientific, Inc.
  • VWR International LLC

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP-7986

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Biopreservation Market to Reach $7.9 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Biopreservation estimated at US$4.4 Billion in the year 2022, is projected to reach a revised size of US$7.9 Billion by 2030, growing at aCAGR of 7.5% over the period 2022-2030. Biopreservation Media, one of the segments analyzed in the report, is projected to record 8.5% CAGR and reach US$5.1 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Biopreservation Equipment segment is readjusted to a revised 6% CAGR for the next 8-year period.

The U.S. Market is Estimated at $1.2 Billion, While China is Forecast to Grow at 12.6% CAGR

The Biopreservation market in the U.S. is estimated at US$1.2 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$2 Billion by the year 2030 trailing a CAGR of 12.6% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.8% and 6.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Select Competitors (Total 27 Featured):

  • Atlanta Biologicals, Inc.
  • BioCision, LLC
  • BioGenix, LLC
  • BioLife Solutions, Inc.
  • Biomatrica, Inc.
  • LabVantage Solutions, Inc.
  • Panasonic Corporation
  • Qiagen, Inc.
  • Thermo Fisher Scientific, Inc.
  • VWR International LLC

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Biopreservation - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Biopreservation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 2: World 8-Year Perspective for Biopreservation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2023 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Biopreservation Media by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 4: World 8-Year Perspective for Biopreservation Media by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Biopreservation Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 6: World 8-Year Perspective for Biopreservation Equipment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Human Tissue Samples by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 8: World 8-Year Perspective for Human Tissue Samples by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Organs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 10: World 8-Year Perspective for Organs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 12: World 8-Year Perspective for Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Other Biospecimens by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 14: World 8-Year Perspective for Other Biospecimens by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
    • TABLE 15: World Recent Past, Current & Future Analysis for Therapeutic Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 16: World 8-Year Perspective for Therapeutic Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Research Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 18: World 8-Year Perspective for Research Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Clinical Trials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 20: World 8-Year Perspective for Clinical Trials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
    • TABLE 21: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 22: World 8-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Biobanks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 24: World 8-Year Perspective for Biobanks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Gene Banks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 26: World 8-Year Perspective for Gene Banks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
    • TABLE 27: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 28: World 8-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 30: World 8-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
    • TABLE 31: World Biopreservation Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Biopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 33: USA 8-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2023 & 2030
    • TABLE 34: USA Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 35: USA 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2023 & 2030
    • TABLE 36: USA Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 37: USA 8-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2023 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 39: USA 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2023 & 2030
  • CANADA
    • TABLE 40: Canada Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 41: Canada 8-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2023 & 2030
    • TABLE 42: Canada Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 43: Canada 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2023 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 45: Canada 8-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2023 & 2030
    • TABLE 46: Canada Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 47: Canada 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2023 & 2030
  • JAPAN
    • Biopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 48: Japan Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 49: Japan 8-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2023 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Japan 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2023 & 2030
    • TABLE 52: Japan Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 53: Japan 8-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2023 & 2030
    • TABLE 54: Japan Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 55: Japan 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2023 & 2030
  • CHINA
    • Biopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 57: China 8-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2023 & 2030
    • TABLE 58: China Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 59: China 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2023 & 2030
    • TABLE 60: China Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 61: China 8-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2023 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 63: China 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2023 & 2030
  • EUROPE
    • Biopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 64: Europe Recent Past, Current & Future Analysis for Biopreservation by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 65: Europe 8-Year Perspective for Biopreservation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2023 & 2030
    • TABLE 66: Europe Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 67: Europe 8-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2023 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Europe 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2023 & 2030
    • TABLE 70: Europe Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 71: Europe 8-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2023 & 2030
    • TABLE 72: Europe Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 73: Europe 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2023 & 2030
  • FRANCE
    • Biopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 74: France Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 75: France 8-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2023 & 2030
    • TABLE 76: France Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 77: France 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2023 & 2030
    • TABLE 78: France Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 79: France 8-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2023 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 81: France 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2023 & 2030
  • GERMANY
    • Biopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 82: Germany Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 83: Germany 8-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2023 & 2030
    • TABLE 84: Germany Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 85: Germany 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2023 & 2030
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Germany 8-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2023 & 2030
    • TABLE 88: Germany Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 89: Germany 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2023 & 2030
  • ITALY
    • TABLE 90: Italy Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 91: Italy 8-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2023 & 2030
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Italy 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2023 & 2030
    • TABLE 94: Italy Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 95: Italy 8-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2023 & 2030
    • TABLE 96: Italy Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 97: Italy 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2023 & 2030
  • UNITED KINGDOM
    • Biopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 98: UK Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 99: UK 8-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2023 & 2030
    • TABLE 100: UK Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 101: UK 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2023 & 2030
    • TABLE 102: UK Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 103: UK 8-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2023 & 2030
    • TABLE 104: UK Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 105: UK 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2023 & 2030
  • SPAIN
    • TABLE 106: Spain Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 107: Spain 8-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2023 & 2030
    • TABLE 108: Spain Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 109: Spain 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2023 & 2030
    • TABLE 110: Spain Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 111: Spain 8-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2023 & 2030
    • TABLE 112: Spain Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 113: Spain 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2023 & 2030
  • RUSSIA
    • TABLE 114: Russia Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 115: Russia 8-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2023 & 2030
    • TABLE 116: Russia Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 117: Russia 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2023 & 2030
    • TABLE 118: Russia Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 119: Russia 8-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2023 & 2030
    • TABLE 120: Russia Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 121: Russia 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2023 & 2030
  • REST OF EUROPE
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 123: Rest of Europe 8-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2023 & 2030
    • TABLE 124: Rest of Europe Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 125: Rest of Europe 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2023 & 2030
    • TABLE 126: Rest of Europe Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 127: Rest of Europe 8-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2023 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 129: Rest of Europe 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2023 & 2030
  • ASIA-PACIFIC
    • Biopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 130: Asia-Pacific Recent Past, Current & Future Analysis for Biopreservation by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 131: Asia-Pacific 8-Year Perspective for Biopreservation by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2023 & 2030
    • TABLE 132: Asia-Pacific Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 133: Asia-Pacific 8-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2023 & 2030
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2023 & 2030
    • TABLE 136: Asia-Pacific Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 137: Asia-Pacific 8-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2023 & 2030
    • TABLE 138: Asia-Pacific Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 139: Asia-Pacific 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2023 & 2030
  • AUSTRALIA
    • Biopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
    • TABLE 140: Australia Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 141: Australia 8-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2023 & 2030
    • TABLE 142: Australia Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 143: Australia 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2023 & 2030
    • TABLE 144: Australia Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 145: Australia 8-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2023 & 2030
    • TABLE 146: Australia Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 147: Australia 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2023 & 2030
  • INDIA
    • Biopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
    • TABLE 148: India Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 149: India 8-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2023 & 2030
    • TABLE 150: India Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 151: India 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2023 & 2030
    • TABLE 152: India Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 153: India 8-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2023 & 2030
    • TABLE 154: India Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 155: India 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2023 & 2030
  • SOUTH KOREA
    • TABLE 156: South Korea Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 157: South Korea 8-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2023 & 2030
    • TABLE 158: South Korea Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 159: South Korea 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2023 & 2030
    • TABLE 160: South Korea Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 161: South Korea 8-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2023 & 2030
    • TABLE 162: South Korea Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 163: South Korea 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2023 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 164: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 165: Rest of Asia-Pacific 8-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2023 & 2030
    • TABLE 166: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 167: Rest of Asia-Pacific 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2023 & 2030
    • TABLE 168: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 169: Rest of Asia-Pacific 8-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2023 & 2030
    • TABLE 170: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 171: Rest of Asia-Pacific 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2023 & 2030
  • LATIN AMERICA
    • Biopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
    • TABLE 172: Latin America Recent Past, Current & Future Analysis for Biopreservation by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 173: Latin America 8-Year Perspective for Biopreservation by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2023 & 2030
    • TABLE 174: Latin America Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 175: Latin America 8-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2023 & 2030
    • TABLE 176: Latin America Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 177: Latin America 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2023 & 2030
    • TABLE 178: Latin America Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 179: Latin America 8-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2023 & 2030
    • TABLE 180: Latin America Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 181: Latin America 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2023 & 2030
  • ARGENTINA
    • TABLE 182: Argentina Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 183: Argentina 8-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2023 & 2030
    • TABLE 184: Argentina Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 185: Argentina 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2023 & 2030
    • TABLE 186: Argentina Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 187: Argentina 8-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2023 & 2030
    • TABLE 188: Argentina Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 189: Argentina 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2023 & 2030
  • BRAZIL
    • TABLE 190: Brazil Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 191: Brazil 8-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2023 & 2030
    • TABLE 192: Brazil Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 193: Brazil 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2023 & 2030
    • TABLE 194: Brazil Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 195: Brazil 8-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2023 & 2030
    • TABLE 196: Brazil Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 197: Brazil 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2023 & 2030
  • MEXICO
    • TABLE 198: Mexico Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 199: Mexico 8-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2023 & 2030
    • TABLE 200: Mexico Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 201: Mexico 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2023 & 2030
    • TABLE 202: Mexico Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 203: Mexico 8-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2023 & 2030
    • TABLE 204: Mexico Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 205: Mexico 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2023 & 2030
  • REST OF LATIN AMERICA
    • TABLE 206: Rest of Latin America Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 207: Rest of Latin America 8-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2023 & 2030
    • TABLE 208: Rest of Latin America Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 209: Rest of Latin America 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2023 & 2030
    • TABLE 210: Rest of Latin America Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 211: Rest of Latin America 8-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2023 & 2030
    • TABLE 212: Rest of Latin America Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 213: Rest of Latin America 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2023 & 2030
  • MIDDLE EAST
    • Biopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
    • TABLE 214: Middle East Recent Past, Current & Future Analysis for Biopreservation by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 215: Middle East 8-Year Perspective for Biopreservation by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2023 & 2030
    • TABLE 216: Middle East Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 217: Middle East 8-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2023 & 2030
    • TABLE 218: Middle East Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 219: Middle East 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2023 & 2030
    • TABLE 220: Middle East Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 221: Middle East 8-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2023 & 2030
    • TABLE 222: Middle East Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 223: Middle East 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2023 & 2030
  • IRAN
    • TABLE 224: Iran Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 225: Iran 8-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2023 & 2030
    • TABLE 226: Iran Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 227: Iran 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2023 & 2030
    • TABLE 228: Iran Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 229: Iran 8-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2023 & 2030
    • TABLE 230: Iran Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 231: Iran 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2023 & 2030
  • ISRAEL
    • TABLE 232: Israel Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 233: Israel 8-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2023 & 2030
    • TABLE 234: Israel Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 235: Israel 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2023 & 2030
    • TABLE 236: Israel Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 237: Israel 8-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2023 & 2030
    • TABLE 238: Israel Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 239: Israel 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2023 & 2030
  • SAUDI ARABIA
    • TABLE 240: Saudi Arabia Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 241: Saudi Arabia 8-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2023 & 2030
    • TABLE 242: Saudi Arabia Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 243: Saudi Arabia 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2023 & 2030
    • TABLE 244: Saudi Arabia Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 245: Saudi Arabia 8-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2023 & 2030
    • TABLE 246: Saudi Arabia Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 247: Saudi Arabia 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2023 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 248: UAE Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 249: UAE 8-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2023 & 2030
    • TABLE 250: UAE Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 251: UAE 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2023 & 2030
    • TABLE 252: UAE Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 253: UAE 8-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2023 & 2030
    • TABLE 254: UAE Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 255: UAE 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2023 & 2030
  • REST OF MIDDLE EAST
    • TABLE 256: Rest of Middle East Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 257: Rest of Middle East 8-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2023 & 2030
    • TABLE 258: Rest of Middle East Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 259: Rest of Middle East 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2023 & 2030
    • TABLE 260: Rest of Middle East Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 261: Rest of Middle East 8-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2023 & 2030
    • TABLE 262: Rest of Middle East Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 263: Rest of Middle East 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2023 & 2030
  • AFRICA
    • Biopreservation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
    • TABLE 264: Africa Recent Past, Current & Future Analysis for Biopreservation by Product Type - Biopreservation Media and Biopreservation Equipment - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 265: Africa 8-Year Perspective for Biopreservation by Product Type - Percentage Breakdown of Value Sales for Biopreservation Media and Biopreservation Equipment for the Years 2023 & 2030
    • TABLE 266: Africa Recent Past, Current & Future Analysis for Biopreservation by Application - Therapeutic Applications, Research Applications, Clinical Trials and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 267: Africa 8-Year Perspective for Biopreservation by Application - Percentage Breakdown of Value Sales for Therapeutic Applications, Research Applications, Clinical Trials and Other Applications for the Years 2023 & 2030
    • TABLE 268: Africa Recent Past, Current & Future Analysis for Biopreservation by Biospecimen - Human Tissue Samples, Organs, Stem Cells and Other Biospecimens - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 269: Africa 8-Year Perspective for Biopreservation by Biospecimen - Percentage Breakdown of Value Sales for Human Tissue Samples, Organs, Stem Cells and Other Biospecimens for the Years 2023 & 2030
    • TABLE 270: Africa Recent Past, Current & Future Analysis for Biopreservation by End-Use - Biobanks, Gene Banks, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 271: Africa 8-Year Perspective for Biopreservation by End-Use - Percentage Breakdown of Value Sales for Biobanks, Gene Banks, Hospitals and Other End-Uses for the Years 2023 & 2030

IV. COMPETITION